-
Document de presse | 2020.10.15
Innate immunity and fusion of cells infected with SARS-CoV-2
Innate immunity is the fastest-acting component of the immune system, but so far little is known about its role during infection with SARS-CoV-2. A few hours after an infection, the body emits an alarm signal, interferon, enabling cells that have not yet been infected to produce antiviral proteins. This phenomenon occurs well before the production of neutralizing antibodies. Scientists from the...
-
Page avancée | 2020.08.27
Startups alumni
Since the first spin-off set up in 1997, many companies have launched their business at the Institut Pasteur and generally maintain ties with the Institute.
-
Page avancée | 2020.08.28
Industry Partnerships
Partnering with industrial operators is the way to succeed in technology development to transform inventions into successful products for the benefit of patients and public health. The Institut Pasteur and its industrial partners are collaborating to achieve this goal.
-
Article | 2020.09.01
2023 Annual Report - Institut Pasteur
The purpose of the Institut Pasteur Annual Report is to describe the significant advances, the scientific breakthroughs and the different highlights that have been achieved over the past year.
-
News | 2020.09.03
Monkeypox: the epidemic potential will continue increasing, with diminishing herd immunity against viruses responsible for smallpox
Monkeypox is an emerging infectious disease for which outbreak frequency and expected outbreak size in human populations have steadily increased. The geographic spread of monkeypox cases has expanded beyond the forests of central Africa, where cases were initially found, to other parts of the world, where cases have been imported. This transmission pattern is likely due to the worldwide decline...
-
Document de presse | 2021.01.19
COVID-19: a lentiviral vaccine candidate for intranasal administration provides sterilizing protection in animal models
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical models, of a COVID-19 vaccine candidate using a lentiviral vector administered by nasal route. Their study demonstrates that the vaccine candidate induces antibody response with strong neutralizing activity against SARS-CoV-2, as well as...
-
Page avancée | 2020.09.15
Startup creation
Startup creation plays a major role in the downstream development of technologies stemming from academic research. With the creation of its first spin-off twenty years ago, the Institut Pasteur was a forerunner in supporting the creation and development of biotech companies.To date, the Institut Pasteur has participated in the creation and/or development of 30 startups harnessing technologies and...
-
Document de presse | 2020.09.10
Editorial: How can we reach a level of herd immunity that will protect us from COVID-19?
Epidemiological theory teaches us that a microbial agent introduced into a population stops circulating when the proportion of the population that is immune to that agent is higher than or equal to 1-1/R0, where R0 is the much-discussed reproduction rate, the number of secondary cases generated by each infected person in a non-immune population in the absence of control measures. In France, where...
-
CNR/CCOMS | 2020.09.17
CRBIP DOCUMENTS
Download the CRBIP LeaftetDownload the CRBIP Quality Manual
-
News | 2020.07.27
"Mental anchorpoints" used by musicians to identify pitch
How do we recognize pitch? An observational study carried out by the Institut Pasteur with the support of the French Society of Authors, Composers and Publishers of Music (SACEM), involving interviews with nearly 70 musicians (music students and professionals), addressed this question and found some initial answers. Musicians recognize pitch by drawing on three mental sensory modalities (auditory...
